Results 1 to 10 of about 30,636 (254)

Takayasu Arteritis in a 55-Year-Old Woman With Prior <i>Mycobacterium leprae</i> Infection: A Possible Postinfectious Association. [PDF]

open access: yesClin Case Rep
ABSTRACT Takayasu arteritis (TAK) is a rare large‐vessel vasculitis affecting the aorta and its major branches. Although autoimmune mechanisms are central, prior mycobacterial infections have been hypothesized to contribute to the disease onset. A 55‐year‐old South Asian woman with a history of vitiligo and treated multibacillary leprosy presented with
Bhattarai U   +7 more
europepmc   +2 more sources

Insights on Mycobacterium leprae Efflux Pumps and Their Implications in Drug Resistance and Virulence [PDF]

open access: goldFrontiers in Microbiology, 2018
Drug resistance in Mycobacterium leprae is assumed to be due to genetic alterations in the drug targets and reduced cell wall permeability. However, as observed in Mycobacterium tuberculosis, drug resistance may also result from the overactivity of ...
Diana Machado   +13 more
doaj   +2 more sources

Mycobacterium leprae and Mycobacterium lepromatosis in small mammals in Midwest Brazil [PDF]

open access: yesBrazilian Journal of Infectious Diseases
Leprosy is a chronic infectious disease caused by the bacilli Mycobacterium leprae and Mycobacterium lepromatosis. In addition to humans, animals such as nine-banded armadillos and red squirrels are species naturally infected. The objective of this study
Beatriz Silva Nogueira   +4 more
doaj   +2 more sources

Sensitivity of Mycobacterium leprae to Telacebec [PDF]

open access: yesEmerging Infectious Diseases, 2022
The treatment of leprosy is long and complex, benefiting from the development of sterilizing, rapidly-acting drugs. Reductive evolution made Mycobacterium leprae exquisitely sensitive to Telacebec, a phase 2 drug candidate for tuberculosis.
Ramanuj Lahiri   +3 more
doaj   +4 more sources

Reverse vaccinology and subtractive genomics approaches for identifying common therapeutics against Mycobacterium leprae and Mycobacterium lepromatosis [PDF]

open access: yesJournal of Venomous Animals and Toxins including Tropical Diseases, 2021
Background Mycobacterium leprae and Mycobacterium lepromatosis are gram-positive bacterial pathogens and the causative agents of leprosy in humans across the world.
Arun Kumar Jaiswal   +12 more
doaj   +1 more source

The genetic determinants of Mycobacterium leprae resistance to antimicrobial drugs [PDF]

open access: yesVestnik Dermatologii i Venerologii, 2021
The review is devoted to the appearance of resistance of a slowly developing disease leprosy to antimicrobial therapy (AMP), primarily recommended by the World Health Organization.
Dmitry A. Verbenko   +3 more
doaj   +1 more source

Construction and Analysis of the Complete Genome Sequence of Leprosy Agent Mycobacterium lepromatosis

open access: yesMicrobiology Spectrum, 2022
Leprosy is caused by Mycobacterium leprae and Mycobacterium lepromatosis. We report construction and analyses of the complete genome sequence of M. lepromatosis FJ924.
Francisco J. Silva   +4 more
doaj   +1 more source

Lepra Bubalorum, a Potential Reservoir of Mycobacterium leprae [PDF]

open access: yesFrontiers in Microbiology, 2021
In 1926, a mycobacterial skin disease was observed in water buffaloes by researchers in Indonesia. The disease was designated as skin tuberculosis, though it was hypothesized that it might be a form of leprosy or a leprosy-like disease. In a follow-up study (Ph.D.
William R. Faber   +4 more
openaire   +5 more sources

Mycobacterium leprae on Palatine Tonsils and Adenoids of Asymptomatic Patients, Brazil

open access: yesEmerging Infectious Diseases, 2020
We investigated palatine tonsil and adenoid specimens excised from otorhinolaryngological patients in a leprosy-endemic region of Brazil. Fite-Faraco staining identified Mycobacterium spp. in 9 of 397 specimen blocks.
Marilda Aparecida Milanez Morgado de Abreu   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy